Bank Of America Corp Cti Biopharma Corp Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$4.2 - $6.01 $10.9 Million - $15.5 Million	2,584,316 Added 278.97%	3,510,679 $14.7 Million
Q4 2022 Feb 10, 2023	BUY	$4.45 - $6.17 $940,285 - $1.3 Million	211,300 Added 29.55%	926,363 $5.57 Million
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $2.45 Million - $3.4 Million	457,780 Added 177.93%	715,063 $4.16 Million
Q2 2022 Aug 12, 2022	BUY	$3.55 - $6.27 $892,409 - $1.58 Million	251,383 Added 4260.73%	257,283 $1.54 Million
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $8,743 - $24,068	4,602 Added 354.55%	5,900 $28,000

Q4 2021 Feb 08, 2022	SELL	$1.44 - $2.86 $34,290 - $68,105	-23,813 Reduced 94.83%	1,298 $3,000
Q3 2021 Nov 15, 2021	BUY	$2.25 - $3.18 $56,425 - $79,748	25,078 Added 75993.94%	25,111 $74,000
Q2 2021 Sep 13, 2021	BUY	$2.16 - $2.62 $71 - $86	33 New	33 $0

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.